Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Q1 2022 Tandem Diabetes Care Inc Earnings Call Transcript

May 04, 2022 / 08:30PM GMT
Release Date Price: €91.02 (-2.03%)
Operator

Thank you for standing by, and welcome to Tandem's First Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be aware that today's call is being recorded. (Operator Instructions)

I would now like to turn the call over to Susan Morrison, EVP and Chief Administrative Officer.

Susan M. Morrison
Tandem Diabetes Care, Inc. - Executive VP & Chief Administrative Officer

Thanks, and good afternoon, everyone. Welcome to Tandem's 2022 First Quarter Earnings Call. Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development time lines and financial performance and operating plans and speak only as of today's date.

There are risks and uncertainties that could cause our actual results to differ materially from those anticipated or projected in our forward-looking statements. A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot